On September 24, JDRF is hosting the 2017 JDRF TELUS Walk to Cure Diabetes, to raise awareness and funds and help change the face of type one diabetes (T1D) forever.

A local walk is being held at Rotary Park, Cranbrook, with registrations and exhibits open at 11:30 a.m. and the walk starting at 1 p.m.

“In the last decade, there have been some incredible advancements in the areas of encapsulation, transplantation, stem cell therapies and artificial pancreas research that have helped move us even closer to a cure,” says Dave Prowten, President and CEO of JDRF Canada. “We want to make these advancements happen sooner, but to do this, we need to step up our fundraising efforts. I want to thank everyone walking with us for playing a vital role in helping us reach our fundraising goals so we can continue to support important research breakthroughs that impact the lives of those living with type 1 diabetes.”

”Our title sponsor TELUS continues to help generate public awareness and raise critical funds for T1D research,” continued Prowten. “Over the past 10 years, the TELUS team has contributed more than $10 million to JDRF. Supporters like TELUS have enabled JDRF’s Canadian Clinical Trials Network to conduct research that will change the lives of hundreds of thousands of people with T1D. Since TELUS first became title sponsor in 2007, the Walk has raised almost $80 million.”

“As an organization committed to using technology to drive better health outcomes for all Canadians, we are proud to be actively involved in a community that is innovating to find a cure for type 1 diabetes,” said Paul Lepage, President of TELUS Health. “In 2016 alone, over 4,500 members of the TELUS family walked in over 50 communities and raised more than $380,000. Together, we are making, and will continue to make, great strides toward curing diabetes.”

“On behalf of JDRF, I would like to thank our sponsors – TELUS, Sun Life Financial, and our national supplier SunRype – for their enthusiasm and dedication. Together, we can help turn type one into type none,” said Prowten.

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. JDRF is the largest charitable supporter of T1D research.

Submitted

Article Share